West Pharmaceutical Services, Inc. (WST) — Analyst outlook / Analyst consensus target is. Based on 14 analyst ratings, the consensus is bullish — 10 Buy, 3 Hold, 1 Sell.
The consensus price target is $303.33 (low: $265.00, high: $340.00), representing an upside of 13.2% from the current price $267.93.
Analysts estimate Earnings Per Share (EPS) of $6.63 and revenue of $2.89B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $6.75 vs est $6.63 (beat +1.8%). 2025: actual $6.83 vs est $7.10 (missed -3.7%). Analyst accuracy: 97%.
WST Stock — 12-Month Price Forecast
$303.33
▲ +13.21% Upside
Average Price Target
Based on 14 Wall Street analysts offering 12-month price targets for West Pharmaceutical Services, Inc., the average price target is $303.33, with a high forecast of $340.00, and a low forecast of $265.00.
The average price target represents a +13.21% change from the last price of $267.93.
Highest Price Target
$340.00
Average Price Target
$303.33
Lowest Price Target
$265.00
WST Analyst Ratings
Buy
Based on 14 analysts giving stock ratings to West Pharmaceutical Services, Inc. in the past 3 months
EPS Estimates — WST
97%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $6.75
vs Est $6.63
▲ 1.8% off
2025
Actual $6.83
vs Est $7.10
▼ 3.9% off
Profitability Outlook
Strong profitability with high earnings per share. EPS trend is improving.
Revenue Estimates — WST
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $2.893B
vs Est $2.885B
▲ 0.3% off
2025
Actual $3.074B
vs Est $3.064B
▲ 0.3% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
